tiprankstipranks
Trending News
More News >
Urogen Pharma (URGN)
NASDAQ:URGN
US Market

Urogen Pharma (URGN) Technical Analysis

Compare
471 Followers

Technical Sentiment

Overall Consensus
Strong Sell
3Bullish
5Neutral
14Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Urogen Pharma’s (URGN) Moving Averages Convergence Divergence (MACD) indicator is -0.21, suggesting Urogen Pharma is a Buy.
Urogen Pharma’s (URGN) 20-Day exponential moving average is 10.27, while Urogen Pharma’s (URGN) share price is $9.87, making it a Sell.
Urogen Pharma’s (URGN) 50-Day exponential moving average is 10.52, while Urogen Pharma’s (URGN) share price is $9.87, making it a Sell.

Urogen Pharma (URGN) Pivot Points

Apr 28, 2025, 07:41 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.73
9.85
9.98
10.10
10.23
10.35
10.48
Fibonacci
9.85
9.95
10.00
10.10
10.20
10.25
10.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Urogen Pharma (URGN) Moving Averages

Apr 28, 2025, 07:41 AM
Period
Simple
Exponential
MA5
9.98Sell
10.01Sell
MA10
10.14Sell
10.09Sell
MA20
10.27Sell
10.27Sell
MA50
10.48Sell
10.52Sell
MA100
10.75Sell
10.94Sell
MA200
12.22Sell
12.15Sell
Urogen Pharma’s (URGN) 10-Day exponential moving average is 10.09, while Urogen Pharma’s (URGN) share price is $9.87, making it a Sell.
Urogen Pharma’s (URGN) 100-Day exponential moving average is 10.94, while Urogen Pharma’s (URGN) share price is $9.87, making it a Sell.
Urogen Pharma’s (URGN) stock price is $9.87 and Urogen Pharma’s (URGN) 50-day simple moving average is 10.48, creating a Sell signal.
Urogen Pharma’s (URGN) stock price is $9.87 and Urogen Pharma’s (URGN) 100-day simple moving average is 10.75, creating a Sell signal.
Urogen Pharma’s (URGN) stock price is $9.87 and Urogen Pharma’s (URGN) 200-day simple moving average is 12.22, creating a Sell signal.

Urogen Pharma (URGN) Technical Indicators

Apr 28, 2025, 07:41 AM
Name
Value
Implied Action
RSI (14)
44.18
Neutral
STOCH (9,6)
52.31
Neutral
STOCHRSI (14)
55.70
Neutral
MACD (12,26)
-0.21
Buy
ADX (14)
16.82
Buy
Williams %R
-50.79
Buy
CCI (14)
-62.24
Neutral
ATR (14)
0.65
-
Ultimate Oscillator
42.64
Neutral
ROC
-3.71
Sell
Urogen Pharma’s (URGN) Relative Strength Index (RSI) is 44.18, creating a Neutral signal.
Urogen Pharma’s (URGN) Trend Strength Indicator (ADX) is 16.82, creating a Buy signal.
Urogen Pharma’s (URGN) Commodity Channel Index (CCI) is -62.24, creating a Neutral signal.
Urogen Pharma’s (URGN) Price Rate of Change (ROC) is -3.71, creating a Sell signal.

FAQ

Is URGN a Buy, Hold, or Sell?
Based on URGN’s technical indicators, URGN is a Strong Sell.
    What is URGN’s RSI (14)?
    URGN’s RSI (14) is 44.18, which suggests URGN is a Neutral.
      What is URGN’s MACD?
      URGN’s MACD is -0.21, which suggests URGN is a Buy.
        What is URGN’s 5-day moving average?
        URGN’s 5-day moving average is 9.98, which suggests URGN is a Sell.
          What is URGN’s 20-day moving average?
          URGN 20-day moving average is 10.27, which suggests URGN is a Sell.
            What is URGN’s 50-day moving average?
            URGN’s 50-day moving average is 10.48, which suggests URGN is a Sell.
              What is URGN’s 200-day moving average?
              URGN’s 200-day moving average is 12.22, which suggests URGN is a Sell.
                What is URGN’s Williams % R (14)?
                URGN’s Williams % R (14) is -50.79, which suggests URGN is a Buy.
                  What is URGN’s CCI (14)?
                  URGN’s CCI (14) is -62.24, which suggests URGN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis